Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00766311 · ClinicalTrials.gov registry record · NA

Aerobic and Strengthening Exercise for Acute Leukemia

A NA study, sponsored by St. Jude Children's Research Hospital.

Completed
Registry status
NA
Development phase
20
Enrollment target

NCT00766311: Completed NA study, sponsored by St. Jude Children's Research Hospital.

NCT00766311 is a NA study that has completed, run by St. Jude Children's Research Hospital. The registered enrollment target is 20 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00766311, a NA study, has completed, sponsored by St. Jude Children's Research Hospital.

COMPLETED
Registry status
NA
Development phase
20 participants
Enrollment target

Study Summary

Survivors of childhood leukemia have muscle weakness and impaired mobility (physical performance), a higher than expected frequency of obesity, and early mortality from cardiovascular disease. Treatment related neuropathy, cardiotoxicity and general cachexia may complicate physical performance and establish a pattern of sedentary behavior that may lead to a lifetime of inactivity. There is limited evidence that children being treated for leukemia benefit from home exercise programs during the maintenance phase of therapy, particularly in terms of muscle strength and range of motion. However, there are no established guidelines regarding the prescription of exercise for children diagnosed with leukemia. We propose to test the feasibility of an exercise intervention among children being treated for acute lymphoblastic leukemia (ALL) and hypothesize that children who participate in the exercise intervention will demonstrate improvements in gross motor function, strength, flexibility, and cardio respiratory fitness, and that they will have more favorable body composition when compared to the children who are assigned to the usual activity group.

Interventions

  • OTHER Hand grip strength
  • OTHER Gross Motor Function
  • OTHER Knee extension strength
  • OTHER Flexibility
  • OTHER Ankle range of motion

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2008-01
Est. Completion 2011-12
Phase NA

What the finished NCT00766311 record still lists

NCT00766311 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 5 interventions - of which Hand grip strength is the first listed.

NCT00766311 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00766311 about?

NCT00766311 is a clinical study titled "Aerobic and Strengthening Exercise for Acute Leukemia". Survivors of childhood leukemia have muscle weakness and impaired mobility (physical performance), a higher than expected frequency of obesity, and early mortality from cardiovascular disease. Treatment related neuropathy, cardiotoxicity and general cachexia may complicate physical performance and e...

What is the current status of trial NCT00766311?

This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2008-01. Estimated completion is 2011-12.

What interventions are being tested in trial NCT00766311?

The interventions under investigation include: Hand grip strength (OTHER), Gross Motor Function (OTHER), Knee extension strength (OTHER), Flexibility (OTHER), Ankle range of motion (OTHER).

Who is sponsoring clinical trial NCT00766311?

This trial is sponsored by St. Jude Children's Research Hospital, which has 410 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00766311's enrollment target sits among peer trials

20 1768th of 2000 higher than 140 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00573339 · 20 participants

    Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing

  • NCT00692939 · 20 participants · Phase 1

    Autologous Stem Cell Transplantation for Crohn's Disease

  • NCT00967785 · 20 participants · Phase 1

    A Phase I Study of Mozobil in the Treatment of Patients With WHIMS

  • NCT01406691 · 20 participants · Phase 4

    Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00766311, the US trial registry maintained by the National Library of Medicine. NCT00766311 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.